Evidence mapPaperPMID 35280815Full record

ArticleFrontiers in oncology2022

Linear Skeletal Muscle Index and Muscle Attenuation May Be New Prognostic Factors in Colorectal Carcinoma Treated by Radical Resection.

Yang Wang, Yuliuming Wang, Lianjie Ai, Hao Zhang, Guodong Li, Zitong Wang, Xia Jiang, Guoqing Yan, Yunxiao Liu, Chunlin Wang and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yang WangDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yuliuming WangDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lianjie AiDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Hao ZhangDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Guodong LiDepartment of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Zitong WangDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xia JiangDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Guoqing YanDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yunxiao LiuDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Chunlin WangDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Huan XiongDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Guiyu WangDepartment of Colorectal Surgery, Cancer Hospital of the University of Chinese Academy of Sciences/Zhejiang Cancer Hospital, Hangzhou, China.
Ming LiuDepartment of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study evaluated the association between body composition and clinical parameters and prognosis in patients with colorectal cancer (CRC) treated by radical resection. Methods: Baseline data on patient age, body mass index (BMI), bowel obstruction and tumor-related factors were collected retrospectively. Body composition parameters such as visceral fat area (VFA), total abdominal muscle area (TAMA), muscle attenuation (MA), posterior renal fat thickness (PPNF) and intermuscular fat area (IMF) are measured using Computed tomography (CT) scans. We also propose a new predictor of linear skeletal muscle index (LSMI) that can be easily measured clinically at CT. Follow-up endpoints were disease-free survival and all-cause death. We follow up with patients in hospital or by telephone. Univariate and multifactorial Cox proportional hazards analyses were performed to identify risk factors associated with prognosis. Survival analysis was performed using the Kaplan-Meier method and a nomogram was established to predict survival. Results: A total of 1761 patients (median age 62 years) with CRC were enrolled in our study, of whom 201 had intestinal obstruction and 673 had a BMI > 24.0. Among all patients, the 3- and 5-year disease-free survival rates were 84.55% and 68.60% respectively, and the overall survival rates were 88.87% and 76.38%. Overall survival was significantly correlated with MA, LSMI, SMI, Tumor size, N stage, metastasis and adjuvant therapy by Cox regression analysis (p < 0.05). The risk of tumor progression was significantly associated with MA, VFA, LSMI, SMI, Male, N stage, metastasis and adjuvant therapy (p < 0.05). In addition, based on the Chinese population, we found that female patients with MA < 30.0 HU, LSMI < 18.2, and SMI < 38.0 had a worse prognosis, male patients with MA < 37.6 HU, LSMI < 21.9, and SMI < 40.3 had a poorer prognosis. Conclusion: Our findings suggest that linear skeletal muscle index and MA can be used as new independent predictors for colorectal cancer patients treated with radical surgery, and that baseline data such as body composition parameters, LSMI and tumor-related factors can collectively predict patient prognosis. These results could help us to optimize the management and treatment of patients after surgery.

Indexed as

body composition parameterscolorectal carcinomacomputed tomography.linear skeletal muscle indexprognostic factorstumor-related factors

Identifiers

PMID35280815
PMCPMC8904745

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.